DiscGenics

DiscGenics is a biotech company in Salt Lake City, United States, founded in 2007. It has raised $64.0M across 2 rounds, most recently a $50.0M Series C in August 2020.

Employees
11–50
Founded
2007
Total Funding
$64.0M
Last Round
$50.0M Series CAug 2020
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds for this company. The full record is or through the API.

About

DiscGenics develops regenerative cell-based biologic drug therapies intended to alleviate pain and restore function in patients with degenerative diseases of the spine. The privately held, clinical-stage organization is led by biopharmaceutical, biologics and medical device executives, practicing clinicians, and innovators in orthopedic, spinal and neurosurgical markets.

Summary

It lists 11–50 employees. It has raised $64.0M in total across 2 rounds, most recently a $50.0M Series C round in Aug 2020.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series CSeries CAug 2020
$50.0M

Sign up to see all 2 events

Funding: Series B through Series C. Amounts, valuations, and investors where available.

Similar Companies

Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

DiscGenics on Indexed.vc
<a href="https://indexed.vc/companies/discgenics"><img src="https://indexed.vc/api/badge/company/discgenics" alt="DiscGenics on Indexed.vc" width="260" height="76" /></a>